Julian Baker and Felix Baker’s Baker Bros. Advisors recently disclosed an increase of around 929,700 shares to its position in Mirati Therapeutics, Inc. (NASDAQ:MRTX).
Keep Reading →
February 4 - Hedge Funds, News
Another one of the funds we track here at Insider Monkey has made a big move into Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), as it was revealed in a filing that Richard...
Keep Reading →
January 26 - Hedge Funds, News
It was revealed in a filing yesterday with the U.S Securities and Exchange Commission that RA Capital Management has opened a large, passive position in Tekmira Pharmaceuticals...
Keep Reading →
January 21 - Hedge Funds, News
As a new filing with the Securities and Exchange Commission showed, Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) has been added to the equity portfolio of Julian and Felix Bakers...
Keep Reading →
January 13 - Hedge Funds, News
James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday.
Keep Reading →
December 29 - Hedge Funds, News
Baker Bros. Advisors, the fund managed by Julian and Felix Baker disclosed changes in two of its activist positions last Thursday.
Keep Reading →
December 15 - Hedge Funds, News
In several new filings with the Securities and Exchange Commission, Julian and Felix Bakers' healthcare-focused fund Baker Bros.
Keep Reading →
November 12 - Hedge Funds, News
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Proteon Therapeutics Inc (NASDAQ:PRTO) are in the spotlight as James E.
Keep Reading →
November 3 - Hedge Funds, News
Scopia Capital Management has disclosed in a recent regulatory filing with the Security and Exchange Commission that it has acquired 4.2 million shares of Aegerion Pharmaceuticals...
Keep Reading →
August 12 - Hedge Funds, News
Kevin Kotler is bullish on Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) and has decided to boost his fund's investment in the stock.
Keep Reading →
July 22 - Hedge Funds, News
In a new filing with the Securities and Exchange Commission, James E. Flynn of Deerfield Management, has revealed a 6.05% stake in Aerie Pharmaceuticals Inc (NASDAQ:AERI).
Keep Reading →
July 7 - Hedge Funds, News
Stephen Dubois is optimistic about the prospects of Genomic Health, Inc. (NASDAQ:GHDX) and has increased his fund's holding of the stock.
Keep Reading →
July 1 - Hedge Funds, News
As a new form 4 filing with the Securities and Exchange Commission showed, Julian and Felix Bakers' Baker Bros Advisors, a fund focused on the biotechnology and healthcare companies...
Keep Reading →
June 25 - Hedge Funds, News
Baker Bros. Advisors, managed by Julian Baker and Felix Baker, have disclosed raising its stake in Seattle Genetics Inc. (NASDAQ:SGEN). In a new filing with the U.S.
Keep Reading →
May 19 - Hedge Funds, News
In a new filing with the SEC, Julian Baker and Felix Baker’s Baker Bros. Advisors revealed new stake in Aquinox Pharmaceuticals Inc (NASDAQ:AQXP).
Keep Reading →
April 14 - Hedge Funds, News
RA Capital Management, managed by Peter Kolchinsky, has revealed a new position in Repros Therapeutics Inc (NASDAQ:RPRX).
Keep Reading →
March 19 - Hedge Funds, News
Julian Baker and Felix Baker’s hedge fund, Baker Bros. Advisors, has recently tweaked its holdings in ACADIA Pharmaceuticals Inc.
Keep Reading →
March 10 - Hedge Funds, News
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio.
Keep Reading →
January 16 - Hedge Funds, News
Julian Baker and Felix Baker's Baker Bros. Advisors have disclosed in a new filing with the SEC adding approximately 4,100 shares to their stake in Genomic Health, Inc.
Keep Reading →
January 6 - Hedge Funds, News
Julian and Felix Baker's Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares revealed as held earlier.
Keep Reading →
January 2 - Hedge Funds, News
Academic research on hedge funds have shown that the stocks bought by hedge funds outperform the market on average.
Keep Reading →
December 24 - Hedge Funds, News
The healthcare sector is usually very attractive to investors, since the companies involved in it have a great potential to grow.
Keep Reading →
December 19 - Hedge Funds, News
Julian Baker and Felix Baker have increased their exposure to Seattle Genetics, Inc. (NASDAQ:SGEN) even higher.
Keep Reading →
December 17 - Hedge Funds, News
Julian Baker and Felix Baker are betting big on Seattle Genetics, Inc. (NASDAQ:SGEN).
Keep Reading →
December 6 - Hedge Funds, News
Julian and Felix Baker and their hedge fund, Baker Bros.
Keep Reading →
November 15 - Hedge Funds, News
Julian and Felix Baker's hedge fund, Baker Bros.
Keep Reading →
November 12 - Hedge Funds, News
In a couple 13D filings with the SEC, Julian and Felix Baker's Baker Bros. Advisors reported a 19.9% stake in Mirati Therapeutics, Inc.
Keep Reading →
October 31 - Hedge Funds, News
Baker Bros., Mirati Therapeutics: In a new form 4 from today, Julian and Felix Baker's Baker Bros. Advisors reported buying 400,000 shares of Mirati Therapeutics, Inc.
Keep Reading →
October 29 - Hedge Funds, News
Repros Therapeutics new drug: Insider Katherine Anderson, Chief Financial Officer at Repros Therapeutics Inc (NASDAQ:RPRX), purchased 1,000 shares of common stock last week at...
Keep Reading →
October 14 - Insider Trading, News
Is Synageva BioPharma a buy? Baker Bros.
Keep Reading →
September 27 - Hedge Funds, News
To the average investor, there are tons of indicators shareholders can use to watch publicly traded companies.
Keep Reading →
September 17 - News
At the moment, there are many indicators market participants can use to watch their holdings. Two of the most under-the-radar are hedge fund and insider trading activity.
Keep Reading →
September 17 - News
Tracking the activity of hedge funds via their filings with the Securities and Exchange Commission is particularly crucial, since these filings reveal the latest moves made by...
Keep Reading →
September 17 - News
Now, according to many investors, hedge funds are assumed to be overrated, outdated investment tools of an era lost to time.
Keep Reading →
September 17 - News
To the average investor, there are tons of methods market participants can use to track publicly traded companies.
Keep Reading →
September 13 - News
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment.
Keep Reading →
September 10 - News
As fast as we can type this, Phill Gross and Robert Atchinson's hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares of Onyx Pharmaceuticals, ...
Keep Reading →
September 9 - News
In the 21st century investor’s toolkit, there are plenty of indicators market participants can use to analyze their holdings.
Keep Reading →
September 6 - News
In the eyes of many of your fellow readers, hedge funds are viewed as overrated, outdated financial tools of a forgotten age.
Keep Reading →
September 5 - News
Now, according to many investors, hedge funds are seen as delayed, outdated financial tools of an era lost to time.
Keep Reading →
September 4 - News
To many of your peers, hedge funds are viewed as bloated, outdated financial vehicles of a forgotten age.
Keep Reading →
September 4 - News
At the moment, there are plenty of metrics market participants can use to monitor the equity markets.
Keep Reading →
September 3 - News
In the 21st century investor’s toolkit, there are many metrics shareholders can use to monitor stocks.
Keep Reading →
September 3 - News
At the moment, there are tons of methods market participants can use to watch Mr. Market. A pair of the most useful are hedge fund and insider trading sentiment.
Keep Reading →
September 3 - News
To many market players, hedge funds are perceived as delayed, old financial tools of a period lost to current times.
Keep Reading →
September 3 - News
In the 21st century investor’s toolkit, there are plenty of indicators investors can use to monitor stocks. Some of the best are hedge fund and insider trading movement.
Keep Reading →
September 3 - News
In the financial world, there are many indicators shareholders can use to analyze Mr. Market. A pair of the most innovative are hedge fund and insider trading activity.
Keep Reading →
August 30 - News
In the 21st century investor’s toolkit, there are many gauges shareholders can use to track their holdings.
Keep Reading →
August 30 - News
If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era lost to time.
Keep Reading →
August 28 - News
To many of your fellow readers, hedge funds are assumed to be useless, old investment vehicles of a period lost to current times.
Keep Reading →
August 28 - News
